Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2025-12-24 @ 5:38 PM
NCT ID:
NCT03305068
Eligibility Criteria:
Inclusion / Exclusion Criteria for Pfizer Study
Inclusion Criteria:
1. community ambulators
2. D/C to home only
3. only MO and IL pts
4. Primary unilateral shoulder replacements / Cuff tear
5. Full Thickness, single tendon tear
Exclusion Criteria:
1. allergy, sensitivity, or inability to take Celebrex
2. CR \>1.5
3. h/o bleeding ulcers
4. h/o Inflammatory bowel disease, Crohn's disease, ulcerative colitis
5. Coagulation abnormality
6. Coumadin/Plavix/Xaralto
7. CHF
8. Previous MI or CVA
9. Current use of long acting narcotics (Fentanyl Patches, Oxycontin CR, MS Contin)
10. Refusal by PCP or cardiologist
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03305068
Study Brief:
Protocol Section:
NCT03305068